Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.

Documenti analoghi

• (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.
  di: Maudgal, P C, et al.
  Pubblicazione: (1980)
• (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.
  di: De Clercq, E, et al.
  Pubblicazione: (1979)
• Pharmacokinetics of E-5-(2-Bromovinyl)-2′-Deoxyuridine in Mice
  di: de Clercq, E., et al.
  Pubblicazione: (1979)
• In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
  di: De Clercq, E, et al.
  Pubblicazione: (1982)
• Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
  di: De Clercq, E, et al.
  Pubblicazione: (1983)